← Leaderboards
Namal Liyanage
Ohio State University
$2,115,564
Attributed
$4,126,551
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,126,551 · 4
By mechanism
U01$3,016,481 · 1
R21$845,670 · 2
K22$264,400 · 1
Top collaborators
- Sahera Dirajlal-Fargo4 shared
- Nicholas T. Funderburg4 shared
Most similar at Ohio State University
Same institution · by research overlap
- Gail A McKoon$4,225,682
- Roger Ratcliff$9,919,804
- Peter G. Shields$24,078,159
- Mary Ellen Wewers$16,751,966
- Harold I Saavedra$5,351,064
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsNatural Killer CellsPhenotypeImmunityAntiretroviral TherapyFlow CytometryLinkHigh DimensionalityPharmaceutical PreparationsInflammationPathway InteractionsCytometryPersonsEpigenetic ProcessImmuneCollaborationsImmune ActivationGene Expression ProfileComorbidityAdultChronicHiv InfectionsCell PhysiologyExperimental Study
Grant awards (9)
The role of Trained Immunity and Mitochondrial dysfunction on INnate immunity in children and adolescents aGing with PHIV (TIMING-PHIV)$747,219
U01 · FY2025 · AI
Enhanced Antibody-Dependent Cellular Cytotoxicity in HIV Vaccine by Novel Adjuvant$433,125
R21 · FY2025 · AI · contact PI
Understanding the Mechanism of HIV Associated with Diabetic Complications in Low- and Middle-Income Country$179,092
R21 · FY2025 · TW · contact PI
The role of Trained Immunity and Mitochondrial dysfunction on INnate immunity in children and adolescents aGing with PHIV (TIMING-PHIV)$752,119
U01 · FY2024 · AI
Understanding the Mechanism of HIV Associated with Diabetic Complications in Low- and Middle-Income Country$233,453
R21 · FY2024 · TW · contact PI
The role of Trained Immunity and Mitochondrial dysfunction on INnate immunity in children and adolescents aGing with PHIV (TIMING-PHIV)$758,050
U01 · FY2023 · AI
The role of Trained Immunity and Mitochondrial dysfunction on INnate immunity in children and adolescents aGing with PHIV (TIMING-PHIV)$759,093
U01 · FY2022 · AI
Retooling Natural killers cells (NK) and mucosal Innate lymphoid cells (ILCs) for an effective HIV vaccine$108,000
K22 · FY2019 · AI · contact PI
Retooling Natural killers cells (NK) and mucosal Innate lymphoid cells (ILCs) for an effective HIV vaccine$156,400
K22 · FY2018 · AI · contact PI